Topic: Biotech
Dr. Moira Gunn talks with 2011 International BIO Gene-ius Challenge participant, Michael Zhang, a high school student who discovered a new result for people with cystic fibrosis.
Dr. Moira Gunn learns about the Washington, D.C. non-profit, whose mission it is to educate key policy makers on regenerative medicine and to advocate for favorable public policies from Alliance for Regenerative Medicine's co-founder Micheal Werner and Managing Director, Morrin Ruffin.
Dr. Moira Gunn talks with Biogen Idec Senior Vice President, Gunther Winkler about the Asia-Pacific Biotech landscape.
Dr. Moira Gunn looks at Scientific American's Worldview on biotech with Publishing Director, Jeremy Abbate and Editor of the Worldview Scorecard, Yali Friedman.
Dr. Moira Gunn learns about the global state of biotechnology from the biotech panel at the annual international BIO conference in Washington DC. This years panel featured BIO President Jim Greenwood, Maryland Governor Martin O'Malley, Carnegie-Mellon University Thorne Professor of Entrepreneurship, Art Boni and Senior Fellow of Healthcare Management at University of Pennsylvania, Steve Sammut.
Dr. Moira Gunn talks with two of the lead scientists from the Swiss Tropical and Public Health Institute, where she learns that there are 250 million people in the world, all suffering from malaria. Then it's off to talk about the unusual humanitarian effort at DSM Nutritional Products with Communications officer, Alex Filz.
A flash at 3 AM inspired Wei-Min Shen and Peter Will to use life-like hormones to control robot transformations. Years later, Wei-Min Shen is still learning new advantages of such a novel life-science approach to robotic control. In this interview, Per Sjoborg asks Wei-Min Shen how he defines three-degrees of freedom for his reconfigurable robots, how far Shen's blue-sky dreams reach and how to achieve his practical goals. In this fun exchange, Sjoborg explores the nitty-gritty problems of keeping robots clean, dry and safe before aiming for loftier goals.
Dr. Moira Gunn gets up to speed on advances in nanotechnology with Roland Germann from IBM's Nanotechnology Center Operations and Lord Alec Broers, Chairman, Diamond Light Source, while author Robert Vamosi looks at gadget security.
Dr. Moira Gunn talks with Randy Schatzman and Mark Litton from Alder Biopharmceuticals about they procedure for treating wasting disease as a part of cancer treatment.
Dr. Moira Gunn talks about the history, the challenges and the issues of getting medicine to people versus the legal guarantees of drugs patents with World Trade Organization representatives, Keith Rockwell and Antony Taubman.
